Status:
RECRUITING
A Cross-Sectional Observational Study on Retained Drug Needle Fragments in People Who Use Intravenous Drugs
Lead Sponsor:
Tampere University Hospital
Collaborating Sponsors:
Deaconess Foundation
A-Clinic Foundation
Conditions:
Drug Abuse, Intravenous
Substance Dependence
Eligibility:
All Genders
18+ years
Brief Summary
In addition to the well-known toxicological harms of intravenous drug (IVD) use, there can also be local tissue complications, including infections, venous sclerosis, tissue necrosis, and drug needle ...
Detailed Description
The clinical significance of retained needle fragments remains unknown. Needle retentions can be asymptomatic, cause local symptoms, and can sometimes even lead to dangerous complications such as need...
Eligibility Criteria
No eligibility criteria provided.
Key Trial Info
Start Date :
May 25 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 15 2028
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05679284
Start Date
May 25 2023
End Date
November 15 2028
Last Update
June 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hatanpää Health Center
Tampere, Finland